Advanced Search

 

Study ID Status Title Patient Level Data
113261 Completed A phase I randomized, open-label, clinical study to assess the effect of food and gender on the pharmacokinetics of SRT2104 administered as an oral suspension or capsule formulation to normal healthy volunteers Study Listed on ClinicalStudyDataRequest.com
113263 Terminated A multi-center, randomized, double-blind, parallel-group study to compare the efficacy and safety of fixed-dose Rosiglitazone/Glimepiride combination therapy with Glimepiride monotherapy for 24 weeks in drug naive subjects with type 2 diabetes
113264 Completed Immunogenicity and reactogenicity of a booster dose of GlaxoSmithKline Biologicals’ GSK2036874A vaccine in healthy toddlers Study Listed on ClinicalStudyDataRequest.com
113266 Completed Evaluation of immunological persistence following 3-dose priming with GSK Biologicals’ 10-valent pneumococcal conjugate vaccine in study NCT00808444 and safety and immunogenicity following a booster dose of the same vaccine Study Listed on ClinicalStudyDataRequest.com
113267 Completed Drug Use Investigation of Flutide in Adult Patients with Bronchial Asthma
113268 Completed Drug use investigation for Relenza
113269 Completed Acceptability of Hepatitis B vaccination among General Population
113272 Completed Post Marketing Surveillance of Zyban-SR (Bupropion hydrochloride) in the Treatment of Nicotine Dependence Among Indian Patients
113275 Completed Immunogenicity and Safety Study of GSK Biologicals' Influenza Vaccine GSK2321138A When Administered in Children Study Listed on ClinicalStudyDataRequest.com
113284 Terminated Open-label, multiple dose study to evaluate the parmacokinetics, safety and tolerability of ezogabine/retigabine as adjunctive treatment in subjects aged from 12 years to less than 18 years with partial onset seizures or Lennox-Gastaut syndrome
113287 Completed An open-label, single-center, randomized, 2-way crossover study to evaluate the bioequivalence of retigavine given as the Market Image tablet compared to the retigavine clinical trial tablets. Study Listed on ClinicalStudyDataRequest.com
113299 Completed A randomised, single-blind, placebo-controlled, study toevaluate the safety, tolerability, pharmacodynamics andpharmacokinetics of repeat subcutaneous administration ofotelixizumab in subjects with rheumatoid arthritis Study Listed on ClinicalStudyDataRequest.com
113310 Completed A multi-center, randomized, double-blind, placebo-controlled, five period cross-over study to evaluate the efficacy and safety of selected doses and dose intervals of GW642444 administered via a novel dry powder inhaler (NDPI) in subjects ≥18 years of age with persistent asthma Study Listed on ClinicalStudyDataRequest.com
113312 Completed A Randomized, Placebo-Controlled, Double-Blind, Clinical Study to Assess the Safety, Tolerability and Pharmacokinetics of Oral SRT2104 Capsules Administered to Healthy Elderly Subjects for 28 Days Study Listed on ClinicalStudyDataRequest.com
113314 Completed Immunogenicity and Safety Study of GSK Biologicals' Quadrivalent Influenza Vaccine (GSK2282512A) When Administered in Children Study Listed on ClinicalStudyDataRequest.com
113324 Completed A First Time in Human study to assess the safety, tolerability and pharmacokinetics of GSK356278 (PDE4 inhibitor) in healthy volunteers Study Listed on ClinicalStudyDataRequest.com
113329 Completed Lactic acid levels in children pre- and perinatally treated with antiretrovirals to prevent HIV transmission (Giaquinto; Hyperlactatemia in infants with in utero exposure to ZDV/3TC )
113329_1 Completed Lactic acid levels in children pre- and perinatally treated with antiretrovirals to prevent HIV transmission (Giaquinto; Hyperlactatemia in infants with in utero exposure to ZDV/3TC )
113329_2 Completed Lactic acid levels in children pre- and perinatally treated with antiretrovirals to prevent HIV transmission (Giaquinto; Hyperlactatemia in infants with in utero exposure to ZDV/3TC )
113329_3 Completed Lactic acid levels in children pre- and perinatally treated with antiretrovirals to prevent HIV transmission (Giaquinto; Hyperlactatemia in infants with in utero exposure to ZDV/3TC )
113329_4 Completed Lactic acid levels in children pre- and perinatally treated with antiretrovirals to prevent HIV transmission (Giaquinto; Hyperlactatemia in infants with in utero exposure to ZDV/3TC )
113329_5 Completed Lactic acid levels in children pre- and perinatally treated with antiretrovirals to prevent HIV transmission (Giaquinto; Hyperlactatemia in infants with in utero exposure to ZDV/3TC )
113329_6 Completed Lactic acid levels in children pre- and perinatally treated with antiretrovirals to prevent HIV transmission (Giaquinto; Hyperlactatemia in infants with in utero exposure to ZDV/3TC )
113329_7 Completed Lactic acid levels in children pre- and perinatally treated with antiretrovirals to prevent HIV transmission (Giaquinto; Hyperlactatemia in infants with in utero exposure to ZDV/3TC )
113332 Completed The association between exposure to spironolactone or amiloride and fracture risk among subjects treated with thiazolidinediones

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.